Induction by Dopamine D1 Receptor Agonist ABT-431 of Dyskinesia Similar to Levodopa in Patients With Parkinson Disease | Zendy

Olivier Rascol | Zendy; John G. Nutt | Zendy; Olivier Blin | Zendy; Christopher G. Goetz | Zendy; Joel M. Trugman | Zendy; C Soubrouillard | Zendy; J H Carter | Zendy; L. J. Currie | Zendy; Nelly Fabre | Zendy; Claire Thalamas | Zendy; William J. Giardina | Zendy; Stephen Wright | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Induction by Dopamine D1 Receptor Agonist ABT-431 of Dyskinesia Similar to Levodopa in Patients With Parkinson Disease

Author(s) -

Olivier Rascol,

John G. Nutt,

Olivier Blin,

Christopher G. Goetz,

Joel M. Trugman,

C Soubrouillard,

J H Carter,

L. J. Currie,

Nelly Fabre,

Claire Thalamas,

William J. Giardina,

Stephen Wright

Publication year - 2001

Publication title -

archives of neurology

Language(s) - English

Resource type - Journals

eISSN - 1538-3687

pISSN - 0003-9942

DOI - 10.1001/archneur.58.2.249

Subject(s) - levodopa , dyskinesia , parkinson's disease , dopamine , agonist , pharmacology , medicine , dopamine agonist , dopamine receptor , psychology , disease , dopaminergic , receptor

Dyskinesias are a frequent adverse effect of long-term levodopa therapy. The relative contribution of dopamine D(1) and D(2) receptor function to the pathophysiology of levodopa-induced dyskinesias remains a matter of controversy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research